Bell John K Insider Trades

Insider Trading History

Track insider trading activity for Bell John K. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $2.11k 9,817 shares
Last Trade
Jun 30, 2020 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$34.9k 29 shares
$1,203.65
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $16.2k 75,000 shares
Last Trade
Jun 26, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.8M 39,567 shares
$1,233.75
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $2.11k 9,788 shares
Last Trade
Mar 31, 2020 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$20.2k 29 shares
$696.92
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $2.1k 9,759 shares
Last Trade
Dec 31, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$35k 29 shares
$1,206.97
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $2.1k 9,730 shares
Last Trade
Sep 30, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$28.1k 29 shares
$967.57
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $7.54k 35,000 shares
Last Trade
Sep 13, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$43.6M 35,000 shares
$1,245.47
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $9.63k 44,701 shares
Last Trade
Sep 13, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$43.6M 35,000 shares
$1,245.47
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $8.52k 39,567 shares
Last Trade
Sep 05, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.1M 75,000 shares
$1,067.67
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $2.09k 9,701 shares
Last Trade
Jun 28, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$65.5k 29 shares
$2,257.50
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $0 0 shares
Last Trade
Apr 30, 2019 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.38B 200,000 shares
$6,876.09
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $20.8k 96,711 shares
Last Trade
Mar 29, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.42M 282 shares
$8,574.99
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $20.8k 96,429 shares
Last Trade
Dec 31, 2018 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.69M 282 shares
$5,983.25
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $8.62k 40,000 shares
Last Trade
Nov 08, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$427M 40,000 shares
$10,673.24
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $20.7k 96,147 shares
Last Trade
Sep 28, 2018 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$3.59M 282 shares
$12,731.24
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $20.6k 95,865 shares
Last Trade
Jun 29, 2018 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$3.37M 282 shares
$11,952.49
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $20.6k 95,583 shares
Last Trade
Mar 30, 2018 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$4.64M 282 shares
$16,449.99
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $20.5k 95,301 shares
Last Trade
Dec 31, 2017 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$5.38M 282 shares
$19,074.99
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $20.5k 95,019 shares
Last Trade
Nov 16, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$254M 18,129 shares
$14,017.49
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $16.6k 76,890 shares
Last Trade
Nov 15, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.4M 1,871 shares
$14,089.24
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Director
Holding Value $16.2k 75,019 shares
Last Trade
Sep 29, 2017 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$4.15M 282 shares
$14,699.99
$0.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up